Royal Bank Of Canada Inmune Bio, Inc. Transaction History
Royal Bank Of Canada
- $422 Billion
- Q1 2024
A detailed history of Royal Bank Of Canada transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 82,736 shares of INMB stock, worth $667,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,736
Previous 57,791
43.16%
Holding current value
$667,679
Previous $650,000
49.54%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INMB
# of Institutions
57Shares Held
2.88MCall Options Held
44.6KPut Options Held
3.5K-
Vanguard Group Inc Valley Forge, PA541KShares$4.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY240KShares$1.94 Million0.0% of portfolio
-
Mai Capital Management181KShares$1.46 Million0.02% of portfolio
-
Rhenman & Partners Asset Management Ab Stockholm, V7178KShares$1.44 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$1.38 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $145M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...